Abstract
The objective of this study is to evaluate how increasing MMR infant vaccination coverage in recent years has modified the epidemiology of rubella in Italy. A cross-sectional population-based seroprevalence study of rubella antibodies was conducted on 3094 sera, in 2004, and results were compared with data obtained by the same method in 1996. The overall proportion of rubella-seropositive individuals was found to be significantly higher in 2004 with respect to 1996 (84.6% vs. 77.4%). However, an increase in seropositivity was observed only in the 1-19 years age groups. Recent increases in childhood MMR vaccination coverage, therefore, have not had an impact on seroprevalence in women of childbearing age, over 5% of whom remain susceptible to rubella. Preconception screening and postpartum vaccination of susceptible women are fundamental if the WHO target of less than one case of congenital rubella syndrome per 100 000 live births is to be attained.
| Original language | English |
|---|---|
| Pages (from-to) | 555-562 |
| Number of pages | 8 |
| Journal | Epidemiology and Infection |
| Volume | 135 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - May 2007 |
Fingerprint
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- Immunology
Cite this
Rubella seroprofile of the Italian population : An 8-year comparison. / Rota, Maria Cristina; Bella, A.; Gabutti, G.; Giambi, C.; Filia, A.; Guido, M.; De Donno, A.; Crovari, P.; Ciofi degli Atti, M. L.
In: Epidemiology and Infection, Vol. 135, No. 4, 05.2007, p. 555-562.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Rubella seroprofile of the Italian population
T2 - An 8-year comparison
AU - Rota, Maria Cristina
AU - Bella, A.
AU - Gabutti, G.
AU - Giambi, C.
AU - Filia, A.
AU - Guido, M.
AU - De Donno, A.
AU - Crovari, P.
AU - Ciofi degli Atti, M. L.
PY - 2007/5
Y1 - 2007/5
N2 - The objective of this study is to evaluate how increasing MMR infant vaccination coverage in recent years has modified the epidemiology of rubella in Italy. A cross-sectional population-based seroprevalence study of rubella antibodies was conducted on 3094 sera, in 2004, and results were compared with data obtained by the same method in 1996. The overall proportion of rubella-seropositive individuals was found to be significantly higher in 2004 with respect to 1996 (84.6% vs. 77.4%). However, an increase in seropositivity was observed only in the 1-19 years age groups. Recent increases in childhood MMR vaccination coverage, therefore, have not had an impact on seroprevalence in women of childbearing age, over 5% of whom remain susceptible to rubella. Preconception screening and postpartum vaccination of susceptible women are fundamental if the WHO target of less than one case of congenital rubella syndrome per 100 000 live births is to be attained.
AB - The objective of this study is to evaluate how increasing MMR infant vaccination coverage in recent years has modified the epidemiology of rubella in Italy. A cross-sectional population-based seroprevalence study of rubella antibodies was conducted on 3094 sera, in 2004, and results were compared with data obtained by the same method in 1996. The overall proportion of rubella-seropositive individuals was found to be significantly higher in 2004 with respect to 1996 (84.6% vs. 77.4%). However, an increase in seropositivity was observed only in the 1-19 years age groups. Recent increases in childhood MMR vaccination coverage, therefore, have not had an impact on seroprevalence in women of childbearing age, over 5% of whom remain susceptible to rubella. Preconception screening and postpartum vaccination of susceptible women are fundamental if the WHO target of less than one case of congenital rubella syndrome per 100 000 live births is to be attained.
UR - http://www.scopus.com/inward/record.url?scp=34247523266&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34247523266&partnerID=8YFLogxK
U2 - 10.1017/S0950268806007400
DO - 10.1017/S0950268806007400
M3 - Article
C2 - 17076939
AN - SCOPUS:34247523266
VL - 135
SP - 555
EP - 562
JO - Epidemiology and Infection
JF - Epidemiology and Infection
SN - 0950-2688
IS - 4
ER -